Investing.com - Exelixis (NASDAQ: EXEL) reported fourth quarter EPS of $0.33, $0.10 better than the analyst estimate of $0.23. Revenue for the quarter came in at $480M versus the consensus estimate of $481.81M.
Guidance
Exelixis sees FY 2024 revenue of $1.83B-$1.93B versus the analyst consensus of $1.83B.
Exelixis's stock price closed at $21.83. It is up 3.95% in the last 3 months and up 26.26% in the last 12 months.
Exelixis saw 7 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Exelixis's stock price’s past reactions to earnings here.
According to InvestingPro, Exelixis's Financial Health score is "great performance".
Check out Exelixis's recent earnings performance, and Exelixis's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar